Pfizer · 1 day ago
Senior Director, Global Obesity Commercial Development
Pfizer is a leading pharmaceutical company, and they are seeking a Senior Director for Global Obesity Commercial Development. This role is responsible for shaping the commercial development strategy for the global obesity franchise, leading cross-functional integration, and ensuring strategic coherence across the portfolio.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Lead the shaping of Pfizer’s overarching commercial vision and long-range portfolio strategy
Translate market and clinical signals into portfolio-level implications and strategic choices
Partner with R&D, Commercial, Finance, and BD to influence investment and lifecycle strategies
Oversee forecasting frameworks and scenario planning
Identify and shape BD opportunities
Lead global launch readiness strategy across multiple assets
Serve as senior integrator across Commercial, R&D, GAV, PGS, BD, and regions
Shape capabilities and operating model required to deliver strategy
Ensure alignment across global, regional, and market stakeholders
Qualification
Required
Bachelor's degree required
12+ years in commercial and R&D strategy, commercial development, portfolio strategy, or consulting
Leadership shaping end-to-end strategy across multiple assets
Strong financial acumen and experience influencing senior leadership
Exceptional communication and executive presence
Preferred
Advanced degree strongly preferred
Obesity or cardiometabolic experience strongly preferred
Benefits
Participation in Pfizer’s Global Performance Plan with a bonus target of 22.5% of the base salary
Eligibility to participate in our share based long term incentive program
401(k) plan with Pfizer Matching Contributions
Additional Pfizer Retirement Savings Contribution
Paid vacation
Holiday and personal days
Paid caregiver/parental and medical leave
Health benefits to include medical, prescription drug, dental and vision coverage
Company
Pfizer
Pfizer is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines.
Funding
Current Stage
Public CompanyTotal Funding
$38BKey Investors
Starboard Value
2025-11-21Post Ipo Debt· $6B
2024-10-07Post Ipo Equity· $1B
2023-05-16Post Ipo Debt· $31B
Recent News
Springfield Business Journal
2026-02-04
2026-02-04
Company data provided by crunchbase